174 related articles for article (PubMed ID: 32747405)
21. Effect of Exercise Intensity on Exogenous Glucose Requirements to Maintain Stable Glycemia At High Insulin Levels in Type 1 Diabetes.
Shetty VB; Fournier PA; Paramalingam N; Soon W; Roby HC; Jones TW; Davis EA
J Clin Endocrinol Metab; 2021 Jan; 106(1):e83-e93. PubMed ID: 33097945
[TBL] [Abstract][Full Text] [Related]
22. The effect of beta-glucan supplementation on glycemic control and variability in adolescents with type 1 diabetes mellitus.
Bozbulut R; Şanlıer N; Döğer E; Bideci A; Çamurdan O; Cinaz P
Diabetes Res Clin Pract; 2020 Nov; 169():108464. PubMed ID: 32971156
[TBL] [Abstract][Full Text] [Related]
23. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
24. Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.
Van Dalem A; Demeester S; Balti EV; Decochez K; Weets I; Vandemeulebroucke E; Van de Velde U; Walgraeve A; Seret N; De Block C; Ruige J; Gillard P; Keymeulen B; Pipeleers DG; Gorus FK;
Diabetologia; 2015 Dec; 58(12):2753-64. PubMed ID: 26409458
[TBL] [Abstract][Full Text] [Related]
25. Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
Danne T; Cariou B; Buse JB; Garg SK; Rosenstock J; Banks P; Kushner JA; McGuire DK; Peters AL; Sawhney S; Strumph P
Diabetes Care; 2019 May; 42(5):919-930. PubMed ID: 30833371
[TBL] [Abstract][Full Text] [Related]
26. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
Bennetsen SL; Feineis CS; Legaard GE; Lyngbæk MPP; Karstoft K; Ried-Larsen M
Front Endocrinol (Lausanne); 2020; 11():486. PubMed ID: 32903679
[No Abstract] [Full Text] [Related]
28. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
29. Pre-exercise blood glucose affects glycemic variation of aerobic exercise in patients with type 2 diabetes treated with continuous subcutaneous insulin infusion.
Hu Y; Zhang DF; Dai L; Li Z; Li HQ; Li FF; Liu BL; Sun XJ; Ye L; He K; Ma JH
Diabetes Res Clin Pract; 2018 Jul; 141():98-105. PubMed ID: 29730390
[TBL] [Abstract][Full Text] [Related]
30. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
[TBL] [Abstract][Full Text] [Related]
31. Effects of Moderate Cycling Exercise on Blood Glucose Regulation Following Successful Clinical Islet Transplantation.
Yardley JE; Rees JL; Funk DR; Toghi-Eshghi SR; Boulé NG; Senior PA
J Clin Endocrinol Metab; 2019 Feb; 104(2):493-502. PubMed ID: 30403817
[TBL] [Abstract][Full Text] [Related]
32. Continuous Glucose Monitoring at High Altitude-Effects on Glucose Homeostasis.
Hill NE; Deighton K; Matu J; Misra S; Oliver NS; Newman C; Mellor A; O'Hara J; Woods D
Med Sci Sports Exerc; 2018 Aug; 50(8):1679-1686. PubMed ID: 29613998
[TBL] [Abstract][Full Text] [Related]
33. Relationship Between Gastric Emptying and Diurnal Glycemic Control in Type 1 Diabetes Mellitus: A Randomized Trial.
Parthasarathy G; Kudva YC; Low PA; Camilleri M; Basu A; Bharucha AE
J Clin Endocrinol Metab; 2017 Feb; 102(2):398-406. PubMed ID: 27880079
[TBL] [Abstract][Full Text] [Related]
34. Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
Zaharieva DP; McGaugh S; Pooni R; Vienneau T; Ly T; Riddell MC
Diabetes Care; 2019 May; 42(5):824-831. PubMed ID: 30796112
[TBL] [Abstract][Full Text] [Related]
35. Type 1 Diabetes Patients With Different Residual Beta-Cell Function but Similar Age, HBA1c, and Cardiorespiratory Fitness Have Differing Exercise-Induced Angiogenic Cell Mobilisation.
Taylor GS; Shaw A; Scragg JH; Smith K; Campbell MD; McDonald TJ; Shaw JA; Ross MD; West DJ
Front Endocrinol (Lausanne); 2022; 13():797438. PubMed ID: 35222269
[TBL] [Abstract][Full Text] [Related]
36. Afternoon aerobic and resistance exercise have limited impact on 24-h CGM outcomes in adults with type 1 diabetes: A secondary analysis.
Brockman NK; Sigal RJ; Kenny GP; Riddell MC; Perkins BA; Yardley JE
Diabetes Res Clin Pract; 2021 Jul; 177():108874. PubMed ID: 34052249
[TBL] [Abstract][Full Text] [Related]
37. Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study.
Riddell MC; Milliken J
Diabetes Technol Ther; 2011 Aug; 13(8):819-25. PubMed ID: 21599515
[TBL] [Abstract][Full Text] [Related]
38. Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.
Nowak C; Lind M; Sumnik Z; Pelikanova T; Nattero-Chavez L; Lundberg E; Rica I; Martínez-Brocca MA; Ruiz de Adana M; Wahlberg J; Hanas R; Hernandez C; Clemente-León M; Gómez-Gila A; Ferrer Lozano M; Sas T; Pruhova S; Dietrich F; Puente-Marin S; Hannelius U; Casas R; Ludvigsson J
J Clin Endocrinol Metab; 2022 Aug; 107(9):2644-2651. PubMed ID: 35665810
[TBL] [Abstract][Full Text] [Related]
39. A comparison of glycemic parameters and their relationship with C-peptide and Proinsulin levels during partial remission and non-remission periods in children with type 1 diabetes mellitus - a cross-sectional study.
Yeşiltepe-Mutlu G; Çapacı M; Can E; Gökçe T; Bayrakçı G; Muradoğlu S; İncir S; Çakır EP; Hatun Ş
BMC Endocr Disord; 2021 Jan; 21(1):18. PubMed ID: 33485357
[TBL] [Abstract][Full Text] [Related]
40. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
